Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    July 2021
  1. CHAUVIN M, Garambois V, Choblet S, Colombo PE, et al
    Anti-Mullerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival.
    Int J Oncol. 2021;59.
    PubMed     Abstract available


    May 2021
  2. THONGCHOT S, Jamjuntra P, Therasakvichya S, Warnnissorn M, et al
    Interleukin8 released by cancerassociated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells.
    Int J Oncol. 2021;58.
    PubMed     Abstract available


    September 2020
  3. LIU J, Liu D, Liu JJ, Zhao C, et al
    [Corrigendum] Blocking the Nav1.5 channel using eicosapentaenoic acid reduces migration and proliferation of ovarian cancer cells.
    Int J Oncol. 2020 Sep 28. doi: 10.3892/ijo.2020.5129.
    PubMed     Abstract available


  4. LIU L, Yuan L, Huang D, Han Q, et al
    miR126 regulates the progression of epithelial ovarian cancer in vitro and in vivo by targeting VEGFA.
    Int J Oncol. 2020;57:825-834.
    PubMed     Abstract available


    April 2020
  5. GUO F, Zhang K, Li M, Cui L, et al
    miR5083p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.
    Int J Oncol. 2020 Apr 27. doi: 10.3892/ijo.2020.5055.
    PubMed     Abstract available


    January 2020
  6. BU H, Li Y, Jin C, Yu H, et al
    Overexpression of PRC1 indicates a poor prognosis in ovarian cancer.
    Int J Oncol. 2020 Jan 10. doi: 10.3892/ijo.2020.4959.
    PubMed     Abstract available


  7. FENG Y, Tang Y, Mao Y, Liu Y, et al
    PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
    Int J Oncol. 2020 Jan 10. doi: 10.3892/ijo.2020.4958.
    PubMed     Abstract available


    December 2019
  8. LEE SY, Kwon J, Woo JH, Kim KH, et al
    Bcl2l10 mediates the proliferation, invasion and migration of ovarian cancer cells.
    Int J Oncol. 2019 Dec 23. doi: 10.3892/ijo.2019.4949.
    PubMed     Abstract available


    November 2019
  9. LIU Q, Liu H, Li L, Dong X, et al
    ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.
    Int J Oncol. 2019 Nov 14. doi: 10.3892/ijo.2019.4913.
    PubMed     Abstract available


  10. BAI Y, Li LD, Li J, Chen RF, et al
    A FXYD5/TGFbeta/SMAD positive feedback loop drives epithelialtomesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
    Int J Oncol. 2019 Nov 13. doi: 10.3892/ijo.2019.4911.
    PubMed     Abstract available


    September 2019
  11. YE W, Ni Z, Yicheng S, Pan H, et al
    Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNAMeg3/miR421/PDGFRA axis.
    Int J Oncol. 2019 Sep 30. doi: 10.3892/ijo.2019.4887.
    PubMed     Abstract available


  12. LI R, Wang Y, Xu Y, He X, et al
    Silencing the long noncoding RNA, TINCR, a molecular sponge of miR335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Int J Oncol. 2019 Sep 10. doi: 10.3892/ijo.2019.4875.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: